These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Advances in marine microbial symbionts in the china sea and related pharmaceutical metabolites. Li Z Mar Drugs; 2009 Apr; 7(2):113-29. PubMed ID: 19597576 [TBL] [Abstract][Full Text] [Related]
5. From chemical structure to environmental biosynthetic pathways: navigating marine invertebrate-bacteria associations. Schmidt EW Trends Biotechnol; 2005 Sep; 23(9):437-40. PubMed ID: 16038996 [TBL] [Abstract][Full Text] [Related]
6. Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants. Radjasa OK; Vaske YM; Navarro G; Vervoort HC; Tenney K; Linington RG; Crews P Bioorg Med Chem; 2011 Nov; 19(22):6658-74. PubMed ID: 21835627 [TBL] [Abstract][Full Text] [Related]
12. Marine microorganism-invertebrate assemblages: perspectives to solve the "supply problem" in the initial steps of drug discovery. Leal MC; Sheridan C; Osinga R; Dionísio G; Rocha RJ; Silva B; Rosa R; Calado R Mar Drugs; 2014 Jun; 12(7):3929-52. PubMed ID: 24983638 [TBL] [Abstract][Full Text] [Related]
18. Drugs from the seas - current status and microbiological implications. Proksch P; Edrada RA; Ebel R Appl Microbiol Biotechnol; 2002 Jul; 59(2-3):125-34. PubMed ID: 12111137 [TBL] [Abstract][Full Text] [Related]